Qiongqiong Li

Qiongqiong Li

Auto-generated profile, based on publicly available information

Qiongqiong Li

Life Sciences Institute, Yinfeng Biological Group, Ltd., Jinan , Shandong Province , People’s Republic of China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
HWHualong Wang
Hualong Wang
QLQiongqiong Li
Qiongqiong Li
SSSuya Sun
Suya Sun
Sheng ChenSheng Chen
Sheng Chen

3 October 2022 in Stem Cells
Verified
Journal Article
Closed access
PDF file
Fenggang YuFenggang Yu
Fenggang Yu
FLFei Liu
Fei Liu
XLxiaohua liang
xiaohua liang
LDLinwei Duan
Linwei Duan
QLQiongqiong Li
Qiongqiong Li
XZXuening Zhao
Xuening Zhao
Induced pluripotent stem cells (iPSCs) generated from somatic cell sources are pluripotent and capable of indefinite expansion in vitro. They provide an unlimited source of cells that can be differentiated into lung progenitor cells for the potential clinical use in pulmonary regenerative medicine. This review gives a comprehensive overview on recent progress toward the use of iPSCs to generate proximal and distal airway epithelial cells and mix lung organoids. Further, their potential applications and future challenges for the field are discussed, with a focus on the technological hurdles that must be cleared before stem cell therapeutics could be used for clinical treatment.

14 September 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
ZZZili Zhang
Zili Zhang
SCSifan Chen
Sifan Chen
QLQiongqiong Li
Qiongqiong Li
DLDefu Li
Defu Li
YLyuanyuan Li
yuanyuan Li
WLWenju Lu
Wenju Lu
Background. Cigarette smoking (CS) is considered to the predominant risk factor contributing to the etiopathogenesis of chronic obstructive pulmonary disease (COPD); meanwhile, genetic predisposition likely plays a role in determining disease susceptibility. Objectives. We aimed to investigate gene expression trajectories from normal nonsmokers to COPD smokers and disease progression discriminant modeling in response to cigarette smoking. Methods. Small airway epithelial samples of human with different smoking status using fiberoptic bronchoscopy and corresponding rat lung tissues following 0, 3, and 6 months of CS exposure were obtained. The expression of the significant overlapping genes between human and rats was confirmed in 16HBE cells, rat lung tissues, and human peripheral PBMC using qRT-PCR. Binary logistic regression analysis was carried out to establish discrimination models. Results. The integrated bioinformatic analysis of 8 human GEO datasets (293 individuals) and 9 rat transcriptome databases revealed 13 overlapping genes between humans and rats in response to smoking exposure during COPD progression. Of these, 5 genes (AKR1C3/Akr1c3, ERP27/Erp27, AHRR/Ahrr, KCNMB2/Kcnmb2, and MRC1/Mrc1) were consistently identified in both the human and rat and validated by qRT-PCR. Among them, ERP27/Erp27, KCNMB2/Kcnmb2, and MRC1/Mrc1 were newly identified. On the basis of the overlapping gene panel, discriminant models were established with the receiver operating characteristic curve (AUC) of 0.98 (AKR1C3/Akr1c3 + ERP27/Erp27) and 0.99 (AHRR/Ahrr + KCNMB2/Kcnmb2) in differentiating progressive COPD from normal nonsmokers. In addition, we also found that DEG obtained from each expression profile dataset was better than combined analysis as more genes could be identified. Conclusion. This study identified 5 DEG candidates of COPD progression in response to smoking and developed effective and convenient discriminant models that can accurately predict the disease progression.